BioSpace News Archive

AcelRx Pharmaceuticals, Inc. today announced the publication of an article reviewing the use of sufentanil sublingual tablet (SST; DSUVIA ® ) for pain medicine procedures by lead author Dr. Sarang Koushik in Current Pain and Headache Reports.

OS Therapies approved open enrollment for AOST-2121: an open label Phase IIb Trial of OST-HER2 (Listeria monocytogenes) in Recurred, Resected Osteosarcoma (OS). OS is a deadly and debilitating cancer of the bone that usually occurs in adolescence and young adults (AYA).

Movano Inc., a health technology company designing devices that inspire and empower you to live a healthier, happier life, announced it has been awarded three new U.S. patents, increasing its total number of issued U.S. patents to six.

The industry analysis report is considered a valuable source of information about the global Breathing Circuits industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

Pfizer Inc. (NYSE: PFE) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending the conditional marketing authorization (CMA) of Pfizer’s PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets) for the treatment of COVID-19 in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe COVID-19.

Galecto, Inc. today announced the publication of the full results of an investigator-initiated open and randomized trial to evaluate Galecto’s inhaled galectin-3 inhibitor, GB0139.